The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of therapeutic GAS6/AXL inhibition of tumor and stromal cells on DNA damage and response to chemotherapy in ovarian cancer.
 
Mary M Mullen
No Relationships to Disclose
 
Elena Lomonosova
No Relationships to Disclose
 
Hollie M Noia
No Relationships to Disclose
 
Lei Guo
No Relationships to Disclose
 
Lindsay Midori Kuroki
No Relationships to Disclose
 
Andrea M Hagemann
No Relationships to Disclose
 
Carolyn K. McCourt
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
 
Premal H. Thaker
Stock and Other Ownership Interests - Celsion
Consulting or Advisory Role - Abbvie/Stemcentrx; Abbvie/Stemcentrx; Celsion; Clovis Oncology; Iovance Biotherapeutics; Stryker; Tesaro; Unleash
Speakers' Bureau - Merck; Tesaro
Research Funding - Merck (Inst)
 
David Gardner Mutch
Honoraria - Clovis Oncology
Consulting or Advisory Role - lilly
Speakers' Bureau - AstraZeneca
 
Matthew A. Powell
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Genentech/Roche; Tesaro
 
Katherine Cynthia Fuh
Honoraria - Aravive
Consulting or Advisory Role - Aravive
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - AVB-S6-500